Lv1
50 积分 2022-04-13 加入
NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
1个月前
已完结
Dipeptidyl Peptidase Inhibition Accelerates Dendritic Cell Cross Priming of Tumor-Reactive T Cells Resulting in Regression of Established Tumors
2个月前
已关闭
Histone deacetylase inhibitors as immunomodulators in cancer therapeutics
3个月前
已完结
CD8+ T cell killing of MHC class I–deficient tumors
3个月前
已完结
Transcriptional Immunoediting of AML Cells after Allogeneic Hematopoietic Stem Cell Transplantation
4个月前
已完结
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
4个月前
已完结
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
4个月前
已完结
Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism
4个月前
已完结
Two‐Dimensional Design Strategy to Construct Smart Fluorescent Probes for the Precise Tracking of Senescence
5个月前
已完结
Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study
5个月前
已完结
2059-LB: NA-931, a Novel Triple IGF-1/GLP-1/GIP Incretin Receptor Agonist Reduces Body Weight and Improves Metabolic Profile in DIO Mice
皖公网安备34019202002308
